IRADIMED CORPORATION

NasdaqGM:IRMD Stock Report

Market Cap: US$674.6m

IRADIMED Past Earnings Performance

Past criteria checks 5/6

IRADIMED has been growing earnings at an average annual rate of 27.7%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 16.8% per year. IRADIMED's return on equity is 22.3%, and it has net margins of 26.1%.

Key information

27.7%

Earnings growth rate

25.5%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate16.8%
Return on equity22.3%
Net Margin26.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

IRADIMED's (NASDAQ:IRMD) Solid Profits Have Weak Fundamentals

Aug 08
IRADIMED's (NASDAQ:IRMD) Solid Profits Have Weak Fundamentals

Recent updates

IRADIMED's (NASDAQ:IRMD) Solid Profits Have Weak Fundamentals

Aug 08
IRADIMED's (NASDAQ:IRMD) Solid Profits Have Weak Fundamentals

If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Feb 23
If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Feb 07
Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Nov 06
Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

Oct 13
Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Feb 05
At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Iradimed withdraws FDA filing for new infusion pump; prelim Q3 revenue rises 13% Y/Y

Oct 10

IRadimed: Record Revenue Could Translate To Share Price Appreciation

Aug 23

Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

Aug 17
Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

iRadimed Non-GAAP EPS of $0.26 beats by $0.02, revenue of $12.7M beats by $0.06M

Jul 29

IRadimed: Reduce Equity Beta With Upside Capture

Jul 18

IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

Jul 13
IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Feb 05
At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

Jan 12
Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

Revenue & Expenses Breakdown

How IRADIMED makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGM:IRMD Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 247119313
30 Jun 246919303
31 Mar 246818283
31 Dec 236617273
30 Sep 236316263
30 Jun 236015253
31 Mar 235614253
31 Dec 225313232
30 Sep 225013232
30 Jun 224812222
31 Mar 224510212
31 Dec 21429202
30 Sep 21386172
30 Jun 21355172
31 Mar 21321192
31 Dec 20321202
30 Sep 20344232
30 Jun 20365232
31 Mar 203910201
31 Dec 193910201
30 Sep 19368181
30 Jun 19348171
31 Mar 19327161
31 Dec 18306162
30 Sep 18295151
30 Jun 18273152
31 Mar 18252152
31 Dec 17230152
30 Sep 17221142
30 Jun 17243132
31 Mar 17295142
31 Dec 16327141
30 Sep 16358151
30 Jun 16359142
31 Mar 16338132
31 Dec 15318122
30 Sep 15265112
30 Jun 15224101
31 Mar 1519391
31 Dec 1415281
30 Sep 1415271
30 Jun 1414261
31 Mar 1412251
31 Dec 1311251

Quality Earnings: IRMD has high quality earnings.

Growing Profit Margin: IRMD's current net profit margins (26.1%) are higher than last year (25.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: IRMD's earnings have grown significantly by 27.7% per year over the past 5 years.

Accelerating Growth: IRMD's earnings growth over the past year (14.1%) is below its 5-year average (27.7% per year).

Earnings vs Industry: IRMD earnings growth over the past year (14.1%) exceeded the Medical Equipment industry 10.4%.


Return on Equity

High ROE: IRMD's Return on Equity (22.3%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies